Login
$ATMU
$45.00 +$0.54 (1.21%) Close

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
ASSETS
Cash and cash equivalents
Related party receivables
Trade and other receivables, net
Inventories
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Investments and advances related to equity method investees
Goodwill
Intangible assets, net
Other assets
TOTAL ASSETS
LIABILITIES
Accounts payable
Related party payables
Accrued compensation, benefits and retirement costs
Current portion of accrued product warranty
Current maturities of long-term debt
Other accrued expenses
Total current liabilities
Long-term debt
Accrued product warranty
Other liabilities
TOTAL LIABILITIES
EQUITY
Common stock, $0.0001 par value (2,000,000,000 shares authorized, 83,940,943 and 83,504,555 shares issued at June 30, 2026, and December 31, 2025, respectively)
Net parent investment
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock, at cost (2,346,969 shares at June 30, 2026, and 1,995,964 at December 31, 2025)
TOTAL EQUITY
TOTAL LIABILITIES AND EQUITY
Common stock, shares issued (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support